In accordance
with 5 CFR 1320, the information collection is not approved at this
time. Prior to publication of the final rule, the agency should
provide to OMB a summary of all comments received on the proposed
information collection and identify any changes made in response to
these comments.
Inventory as of this Action
Requested
Previously Approved
36 Months From Approved
0
0
0
0
0
0
0
0
0
Respondents to the information
collection are manufacturers of foods that are fermented,
hydrolyzed, or contain fermented or hydrolyzed ingredients and bear
the claim “gluten-free,” “no gluten,” “free of gluten,” or “without
gluten.” It imposes recordkeeping that FDA believes will provide a
reasonable assurance that food so labeled is gluten-free before
fermentation or hydrolysis; that the manufacturer has evaluated the
potential for cross-contact with gluten during the manufacturing
process; and that measures have been taken to prevent the
introduction of gluten into the food during the manufacturing
process.
This is a new information
collection associated with rulemaking.
No
No
No
No
No
Uncollected
Domini Bean 301 796-5733
domini.bean@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.